Qinglai Yang
Overview
Explore the profile of Qinglai Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu F, Kuang X, Deng S, Qi S, Xiong J, Zhao B, et al.
Mater Today Bio
. 2025 Jan;
30:101442.
PMID: 39866786
Hepatocellular carcinoma (HCC) is typically diagnosed at intermediate to advanced stage, making surgical treatment unfeasible. Conversion therapy aims to reduce tumor stage, improve hepatic resection feasibility, and lower recurrence rates....
2.
Wu G, Tan S, Tan X, Chen G, Yang Q
Theranostics
. 2025 Jan;
15(2):384-407.
PMID: 39744691
Malignant tumors have been a serious threat to human health with their increasing incidence. Difficulties with conventional treatments are toxicity, drug resistance, and recurrence. For this reason, non-invasive treatment modalities...
3.
Li N, Wang M, Liu F, Wu P, Wu F, Xiao H, et al.
Anal Chem
. 2024 Nov;
96(49):19585-19596.
PMID: 39603824
The efficacy of immunotherapy in treating triple-negative breast cancer (TNBC) has been restricted due to its low immunogenicity and suppressive immune microenvironment. Bacterial outer membrane vesicles (OMVs) have emerged as...
4.
Li N, Tang J, Wang C, Wang M, Chen G, Jiao L, et al.
Colloids Surf B Biointerfaces
. 2024 Nov;
245:114363.
PMID: 39509851
The rational design of nanozymes with highly efficient reactive oxygen species (ROS) generation to overcome the resistant infection microenvironment still faces a significant challenge. Herein, the highly active Fe single-atom...
5.
Lin N, Wang M, Gong H, Li N, Liu F, Wu Y, et al.
Int J Biol Macromol
. 2024 Aug;
277(Pt 4):134518.
PMID: 39111496
Bacterial biofilm-related infections have become a significant global concern in public health and economy. Extracellular DNA (eDNA) is regarded as one of the key elements of extracellular polymeric substances (EPS)...
6.
Li Z, Yang S, Xiao H, Kang Q, Li N, Wu G, et al.
Bioconjug Chem
. 2024 Jun;
35(7):1015-1023.
PMID: 38904455
Currently, clinical therapeutic strategies for nasopharyngeal carcinoma (NPC) confront insurmountable dilemmas in which surgical resection is incomplete and chemotherapy/radiotherapy has significant side effects. Phototherapy offers a maneuverable, effective, and noninvasive...
7.
Xiao H, Wu G, Tan S, Tan X, Yang Q
Chem Asian J
. 2024 Jan;
19(4):e202301036.
PMID: 38230541
Malignant tumors seriously threaten human life and well-being. Emerging Near-infrared II (NIR-II, 1000-1700 nm) phototheranostic nanotechnology integrates diagnostic and treatment modalities, offering merits including improved tissue penetration and enhanced spatiotemporal...
8.
Pan Q, Li K, Kang X, Li K, Cheng Z, Wang Y, et al.
J Nanobiotechnology
. 2023 Dec;
21(1):489.
PMID: 38111035
Orthotopic advanced hepatic tumor resection without precise location and preoperative downstaging may cause clinical postoperative recurrence and metastasis. Early accurate monitoring and tumor size reduction based on the multifunctional diagnostic-therapeutic...
9.
Zhou W, Li N, Wang M, Wu P, Fu Q, Wang W, et al.
Dalton Trans
. 2023 Dec;
53(2):666-674.
PMID: 38073603
Although antibacterial platforms involving nanozymes have been extensively investigated, there are still problems of poor reactive oxygen species generation efficiency and obstinate bacterial biofilms. Developing a nanozyme-photothermal therapy nanoplatform with...
10.
Wu G, Liu F, Li N, Fu Q, Wang C, Yang S, et al.
Adv Sci (Weinh)
. 2023 Nov;
10(36):e2304104.
PMID: 37983599
Tumor microenvironment (TME)-triggered phototheranostic platform offers a feasible strategy to improve cancer diagnosis accuracy and minimize treatment side effects. Developing a stable and biocompatible molecular phototheranostic platform for TME-activated second...